179 related articles for article (PubMed ID: 23212655)
1. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.
Wen H; Hao J; Li SK
J Pharm Sci; 2013 Mar; 102(3):892-903. PubMed ID: 23212655
[TBL] [Abstract][Full Text] [Related]
2. Influence of molecular shape, conformability, net surface charge, and tissue interaction on transscleral macromolecular diffusion.
Srikantha N; Mourad F; Suhling K; Elsaid N; Levitt J; Chung PH; Somavarapu S; Jackson TL
Exp Eye Res; 2012 Sep; 102():85-92. PubMed ID: 22846670
[TBL] [Abstract][Full Text] [Related]
3. The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.
Cruysberg LP; Nuijts RM; Geroski DH; Gilbert JA; Hendrikse F; Edelhauser HF
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3790-4. PubMed ID: 16186364
[TBL] [Abstract][Full Text] [Related]
4. Diffusion of high molecular weight compounds through sclera.
Ambati J; Canakis CS; Miller JW; Gragoudas ES; Edwards A; Weissgold DJ; Kim I; Delori FC; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1181-5. PubMed ID: 10752958
[TBL] [Abstract][Full Text] [Related]
5. Iontophoretic transport of charged macromolecules across human sclera.
Chopra P; Hao J; Li SK
Int J Pharm; 2010 Mar; 388(1-2):107-13. PubMed ID: 20045044
[TBL] [Abstract][Full Text] [Related]
6. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.
Pitkänen L; Ranta VP; Moilanen H; Urtti A
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):641-6. PubMed ID: 15671294
[TBL] [Abstract][Full Text] [Related]
7. Diffusion of macromolecules through sclera.
Miao H; Wu BD; Tao Y; Li XX
Acta Ophthalmol; 2013 Feb; 91(1):e1-6. PubMed ID: 22998133
[TBL] [Abstract][Full Text] [Related]
8. Photokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera.
Giannos SA; Kraft ER; Zhao ZY; Merkley KH; Cai J
Pharm Res; 2018 Mar; 35(6):110. PubMed ID: 29600470
[TBL] [Abstract][Full Text] [Related]
9. Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules.
Molokhia S; Papangkorn K; Butler C; Higuchi JW; Brar B; Ambati B; Li SK; Higuchi WI
J Ocul Pharmacol Ther; 2020 May; 36(4):247-256. PubMed ID: 32155098
[No Abstract] [Full Text] [Related]
10. In-vitro permeation of bevacizumab through human sclera: effect of iontophoresis application.
Pescina S; Ferrari G; Govoni P; Macaluso C; Padula C; Santi P; Nicoli S
J Pharm Pharmacol; 2010 Sep; 62(9):1189-94. PubMed ID: 20796199
[TBL] [Abstract][Full Text] [Related]
11. Influence of permeant lipophilicity on permeation across human sclera.
Wen H; Hao J; Li SK
Pharm Res; 2010 Nov; 27(11):2446-56. PubMed ID: 20734114
[TBL] [Abstract][Full Text] [Related]
12. VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione.
Miura Y; Klettner A; Roider J
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4848-55. PubMed ID: 20435596
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-enhanced penetration through sclera depends on frequency of sonication and size of macromolecules.
Chau Y; Suen WL; Tse HY; Wong HS
Eur J Pharm Sci; 2017 Mar; 100():273-279. PubMed ID: 28104474
[TBL] [Abstract][Full Text] [Related]
14. In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits.
Berezovsky DE; Patel SR; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7038-45. PubMed ID: 21791594
[TBL] [Abstract][Full Text] [Related]
15. Transscleral passive and iontophoretic transport: theory and analysis.
Li SK; Hao J
Expert Opin Drug Deliv; 2018 Mar; 15(3):283-299. PubMed ID: 29149574
[TBL] [Abstract][Full Text] [Related]
16. Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.
Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4513-22. PubMed ID: 17003447
[TBL] [Abstract][Full Text] [Related]
17. Similarity of permeabilities for Ficoll, pullulan, charge-modified albumin and native albumin across the rat peritoneal membrane.
Asgeirsson D; Axelsson J; Rippe C; Rippe B
Acta Physiol (Oxf); 2009 Aug; 196(4):427-33. PubMed ID: 19141139
[TBL] [Abstract][Full Text] [Related]
18. Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability.
Nicoli S; Ferrari G; Quarta M; Macaluso C; Govoni P; Dallatana D; Santi P
Mol Vis; 2009; 15():259-66. PubMed ID: 19190734
[TBL] [Abstract][Full Text] [Related]
19. Determining vitreous viscosity using fluorescence recovery after photobleaching.
Srikantha N; Teijeiro-Gonzalez Y; Simpson A; Elsaid N; Somavarapu S; Suhling K; Jackson TL
PLoS One; 2022; 17(2):e0261925. PubMed ID: 35143514
[TBL] [Abstract][Full Text] [Related]
20. Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.
Nagai N; Nezhad ZK; Daigaku R; Saijo S; Song Y; Terata K; Hoshi A; Nishizawa M; Nakazawa T; Kaji H; Abe T
Int J Pharm; 2019 Aug; 567():118458. PubMed ID: 31247277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
